South Asian Journal of Cancer

LinksSchließen

Referenz

Foran JM, Rohatiner AZS, Cunningham D. et al
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.

J Clin Oncol 2000;
18 (02) 317-324

Bibliographische Angaben herunterladen

Aufrufen in: